G Medical Innovations jumps 9% on launch plans of Covid-19 testing centers in California

martin-dm/E+ via Getty Images

• G Medical Innovations Holdings (NASDAQ:GMVD) gains 9.4% premarket after announcing plans to open as many as 25 Covid-19 testing centers in California in Q1, 2022.
• Known for its technology, remote patient monitoring devices and services utilized by hospitals and cardiologists across the country, GMedical’s Prizma monitoring device will be offered direct-to-consumer for the first time at these testing locations, as part of a direct-to-consumer strategy.
• Prizma is a cell phone-sized device that can help monitor user’s vital signs, providing ECG readings, temperature, oxygen saturation, heart rate, stress levels and blood pressure, help track body weight and glucose levels.
• With the growth in demand for Covid testing, G Medical expects its new California locations to boost Prizma sales.